Vanguard Group »

Aclaris Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.0M 4.7M 1.05
2023-09-30 $23M 3.4M 6.85
2023-06-30 $35M 3.3M 10.37
2023-03-31 $26M 3.2M 8.09
2022-12-31 $49M 3.1M 15.75
2022-06-30 $39M 2.8M 13.96
2022-03-31 $47M 2.7M 17.24
2021-09-30 $48M 2.7M 18.00
2021-06-30 $45M 2.6M 17.56
2021-03-31 $53M 2.1M 25.20
2020-12-31 $9.7M 1.5M 6.50
2020-09-30 $3.3M 1.3M 2.57
2020-06-30 $2.2M 1.3M 1.66
2020-03-31 $1.5M 1.4M 1.04
2019-12-31 $2.7M 1.4M 1.89
2019-09-30 $1.5M 1.4M 1.09
2019-03-31 $11M 1.8M 5.99
2018-12-31 $5.0M 721k 7.00
2018-09-30 $17M 1.2M 14.52
2018-06-30 $24M 1.2M 19.97
2018-03-31 $21M 1.2M 17.52
2017-12-31 $28M 1.1M 24.67
2017-09-30 $31M 1.2M 26.00
2017-06-30 $22M 812k 27.11
2017-03-31 $21M 712k 29.82
2016-12-31 $16M 605k 27.00
2016-09-30 $11M 426k 25.61
2016-06-30 $7.8M 419k 18.49
2015-12-31 $4.0M 150k 26.91